Can J Gastroenterol Hepatol. 2015 Nov-Dec;29(8):440-4. doi: 10.1155/2015/359640. Epub 2015 Jul 15.
Patients with cirrhosis are known to experience sleep disturbance, which negatively impacts health-related quality of life.
To assess the prevalence and predictors of sleep disturbance before and after liver transplantation (LT).
Both pre- and post-LT patients were administered the Basic Nordic Sleep Questionnaire. The primary outcome was overall sleep satisfaction; the secondary outcomes were sleep latency and sleep duration.
Eighty-three patients participated pre-LT and 273 post-LT. Overall, participants having completed both pre- and post-LT questionnaires reported satisfactory sleep 61% of the time before LT and 65% of the time after LT. However, on review of all questionnaires, patients with alcoholic liver disease (ETOH) experienced dramatically less sleep disturbance (OR 0.13 [95% CI 0.03 to 0.60]) post-LT, whereas those with hepatitis C remained without improvement (OR 0.90 [95% CI [0.38 to 2.15]). On logistic regression, patients with ETOH had statistically less sleep satisfaction pre-LT (OR 5.8 [95% CI 1.0 to 40.5]) and significantly better sleep satisfaction post-LT (OR 0.50 [95% CI 0.20 to 1.00]) compared with those with hepatitis C. In addition, both ETOH and other conditions had significantly better sleep latency than hepatitis C patients.
Sleep parameters for patients who undergo LT for hepatitis C do not improve following LT as much as they do in patients transplanted for ETOH. Following LT, patients transplanted for ETOH are significantly more satisfied with their sleep than those transplanted for hepatitis C. Physicians should address and manage sleep quality after LT, so as to ultimately improve quality of life.
已知肝硬化患者会出现睡眠障碍,这会对健康相关生活质量产生负面影响。
评估肝移植(LT)前后患者睡眠障碍的发生率和预测因素。
对 LT 前后的患者均进行基本北欧睡眠问卷(Basic Nordic Sleep Questionnaire)评估。主要结局为总体睡眠满意度;次要结局为入睡潜伏期和睡眠时间。
83 例患者接受 LT 前评估,273 例患者接受 LT 后评估。总体而言,完成 LT 前后问卷评估的患者在 LT 前有 61%的时间报告睡眠满意度尚可,在 LT 后有 65%的时间报告睡眠满意度尚可。然而,在对所有问卷进行回顾时,患有酒精性肝病(ETOH)的患者在 LT 后睡眠障碍明显减少(OR 0.13 [95%CI 0.03 至 0.60]),而患有丙型肝炎的患者则没有改善(OR 0.90 [95%CI 0.38 至 2.15])。Logistic 回归分析显示,与患有丙型肝炎的患者相比,患有 ETOH 的患者在 LT 前睡眠满意度明显降低(OR 5.8 [95%CI 1.0 至 40.5]),而在 LT 后睡眠满意度显著升高(OR 0.50 [95%CI 0.20 至 1.00])。此外,ETOH 和其他疾病患者的入睡潜伏期均明显长于丙型肝炎患者。
接受 LT 治疗丙型肝炎的患者的睡眠参数在 LT 后并未像接受 ETOH 治疗的患者那样得到改善。LT 后,接受 ETOH 治疗的患者对睡眠的满意度明显高于接受丙型肝炎治疗的患者。医生应在 LT 后关注并管理患者的睡眠质量,从而最终提高生活质量。